Newtopia, Inc. · OTC:NEWUF
Newtopia — Q3 2024 Earnings Presentation
40 slides from Newtopia's earnings presentation, Nov 27, 2024
Slide 1: Healthy Habits for Life
TSXV: NEWU OTC: NEWUF Healthy Habits for Life Corporate Overview November 2024 – Q3
Slide 2: Forward Looking Information
Forward Looking Information Certain statements in this presentation are forward-looking information or forward-looking statements. Such information and statements, referred to herein as “forward-looking statements” are made as of the date of this presentation or as of the date of the effective date
Slide 3: Investment Highlights
Investment Highlights Third-Party Validation: the only tech-enabled habit change provider with Full-Plus CDC accreditation, incorporating genetic data, leveraging HIPAA-compliant technology Marquee Partners: partnering with a growing list of innovative US Fortune 500 employers, health plans & value-
Slide 4: Making Healthy Living a Habit
MEET NEWTOPIA Making Healthy Living a Habit Tech-enabled habit change company – with or without medication - for disease prevention Reducing cost of care and optimizing revenues for risk-bearing payers The only tech-enabled habit change provider with Full- Plus CDC recognition, with industry leading
Slide 5: Clients = Innovative Employers, Health Plans & Providers
Clients = Innovative Employers, Health Plans & Providers Population Access amongst Current Client Base 35% Current Access 65% Opportunity Amongst the client base listed to the right, Newtopia has provided access to roughly 35% of their population, providing significant opportunities for expansion an
Slide 6: What Problem is Newtopia Solving
What Problem is Newtopia Solving 1. Health systems do not adequately support primary prevention, leaving payers intervening too late. 2. GLP-1 Drugs for Obesity and Diabetes require habit change to deliver an ROI for insurers. 3. Health AI Requires High Quality Longitudinal Datasets for applied data
Slide 7: Costs of Chronic Disease Risk to Health Insurers
Costs of Chronic Disease Risk to Health Insurers 20% of the US population has diabetes, heart disease or 80% of the US population has has suffered a at least one stroke INDIRECT risk factor COSTS/ MENTAL HEALTH DIRECT COST/ PHYSICAL HEALTH Healthy 1-2 Risk Factors 3+ Risk Factors Diabetes, Heart Dis
Slide 8: Skyrocketing Demand for GLP-1s = No ROI for Payers
Skyrocketing Demand for GLP-1s = No ROI for Payers Predicted to be the largest and fastest growing new drug class in history with $100B+ market DIRECT COST/ PHYSICAL HEALTH Ozempic, Wegovy, Mounjaro, Zepbound Newtopia $12,000-15,000/year $750/year Average US GLP-1 spend per user Average value-based
Slide 9: Health AI & Applied Data Intelligence
Health AI & Applied Data Intelligence Collecting Longitudinal Anonymized Genetic & Phenotypic data is novel to Newtopia LONGITUDINAL DATABASE (15+ YEARS) Real-Time Analytics Behavioral, Lifestyle Genetics Mental Health Data & SDOH Health AI PRODUCT ENHANCEMENT, R&D, CLINICAL DISCOVERY & HEALTH A
Slide 10: How Does Newtopia Work?
How Does Newtopia Work? ONBOARDING PROGRAM Tracking Risk eligibility Identified* Receive Welcome Kit Coaching Sessions (steps, weight and compliancy) and Registration and Genetic Test (Inspirator frequency depends on month in program) Newtopia App Scheduling, videos, worksheets, goal tracking, snap
Slide 11: Newtopia Value Based Revenue & ROI
Newtopia Value Based Revenue & ROI PARTICIPANT SUBSCRIPTION FEE OUTCOME WELCOME KIT Per Contracted MILESTONE Initial Onboarding Engaged Participant Target: 5% Body + Criteria + Weight Reduction or A1c Reduction One-time Fee, Recurring Revenue, Success Fee, Lower Margins [1] Higher Margins [2] 100% M
Slide 12: Creating ROI for GLP-1s: Newtopia Ally & Sustain
Creating ROI for GLP-1s: Newtopia Ally & Sustain MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB 18% WL 3.5% WL 24% WL (maintained) Healthy habits around nutrition, exercise Maria introduces healthier eating & Maria develops increased awareness of her emotional and mental/emotional wellbeing are now
Slide 13: Newtopia Delivers Industry Leading Engagement
Newtopia Delivers Industry Leading Engagement 36% of Newtopians Achieve Clinically-Significant Outcomes vs. <20% for Chronic Care Vendors 85% 80% 73% 70% 60% 61% 30% 20% 15% 15% 1.5% <5% Targeted Population Active & Active & Active & Active & Population Enrolled Engaged Engaged Engaged Engaged @ 3 M
Slide 14: Sustained Engagement Drives Validated Outcomes
Sustained Habit Engagement Change Outcomes Drives Validated Outcomes Slow Progression of Chronic Disease Newtopia Enriching Mental Health and Improve Mental Health and Well-Being Cost Reduction and ROI ↓ 14.5% Metabolic Severity Risk Score1 35% Lost over 5% body weight by 12th month ↓$1,464 ~50% 77%
Slide 15: Annual Revenue and Gross Profit Margin
Annual Revenue and Gross Profit Margin Revenue Gross Profit Margin 15
Slide 16: Participant Engagements
Participant Engagements # Annual Engagements 490,000 149,000 140,900 135,500 125,000 119,200 120,000 100,000 80,000 60,000 55,700 40,000 33,800 18,500 20,000 12,000 a 2016 2017 2018 2019 2020 2021 2022 2023 newtopia
Slide 17: Deep Understanding of Habit Signals to Build Scale
Deep Understanding of Habit Signals to Build Scale Inspirator to Participant Service Ratio Initiatives 2025 2023 2021 1 : 185 1 : 260 1 : 325 Path to Scale 1 : 350 Streaming Technology Group sessions Automation of operational and administrative Leverage data science to tier participants Increase gro
Slide 18: Making Health Care About Keeping People Healthy
Making Health Care About Keeping People Healthy The only tech-enabled habit change provider with Full-Plus CDC recognition, incorporating genetic data and leveraging HIPAA-compliant technology with industry leading engagement. A growing list of partnerships with innovative US Fortune 500 employers,
Slide 19: Appendix
Appendix 19
Slide 20: Highly Experienced, Driven Management Team
Highly Experienced, Driven Management Team Jeff Ruby Lara Dodo Collin Swenson Peter Seider Founder & Chief Executive Officer Chief Growth & Operations Officer Chief Financial Officer Chief Information, Privacy, & Security Officer Co-founded Cleveland Clinic CEO of TimePlay and Co-Founder Valeo, Sele
Slide 21: Quarterly Revenue & Gross Profit Margin
Quarterly Revenue & Gross Profit Margin Revenue Gross Profit Margin 21
Slide 22: Risk Factors that Contribute to Chronic Conditions
Risk Factors that Contribute to Chronic Conditions 1 5x Waist circumference as likely Untimely death Kidney disease or BMI to develop type 2 diabetes 2 Elevated blood glucose / A1C Vision disability Liver damage 3 Elevated blood pressure 2x as likely to develop Heart problems Weakness heart disease
Slide 23: Genetic Insights. Actionable Recommendations.
Genetic Insights. Actionable Recommendations. Body Fat Gene (FTO) Determines how body breaks down fat How easily do you gain weight? Caffeine Gene (CYP1A2) Determines how quickly we metabolize caffeine Is caffeine impacting your sleep, stress or anxiety levels? Eating Behavior Gene (DRD2) Regulates
Slide 24: Third Party Validations: Clinically Significant Outcomes
Third Party Validations: Clinically Significant Outcomes Evidence Based & Grounded in Science Full-Plus CDC recognition: The U.S. Patent 9,554,754 weight, Aetna sponsored Randomized Case Study: Strategic Incentive Full-Plus 5-yr. distinction is lifestyle and/or disease Control Trial Published in the
Slide 25: Clinically Significant Outcomes: Detailed Version
Clinically Significant Outcomes: Detailed Version Accredited by the Centers of Disease Control (CDC) and US Patent for “Hyper Personalized Disease Prevention Platform” 1 2 3 4 5 6 Aetna Randomized Abstract: Weight Loss Abstract: Abstract: The Effect Santa Barbara Control Trial Published During the C
Slide 26: Aetna Randomized Controlled Trial
Aetna Randomized Controlled Trial Randomized Controlled Study (RCT) shows material savings for clients. 10% 10% Average Body Weight Reduction (%) US$1,464 in savings Annual reduction in medical costs 7.5% Newtopia continues to 2X in-year ROI replicate and improve on RCT results in our 4.3% commercia
Slide 27: Behavioral Economic Trial - 24 Month Outcomes
Behavioral Economic Trial - 24 Month Outcomes ENGAGEMENT* WEIGHT LOSS Over 12 and 24 months 88% & 83% ~48k LB 39% 14% Population engaged on ** Total weight loss Continuously engaged participants Continuously engaged participants average month far exceeding since inception achieved > 5% weight loss b
Slide 28: Medicare Advantage Study
Medicare Advantage Study Santa Barbara Actuaries Research Report: Newtopia Over-65 Population Savings Estimate. Report Highlights 5.5% Anticipated average $1,700 $10.8M body weight reduction Cost savings per MA member Estimated one-year savings for plan with 100,000 members Source: “Newtopia Over-65
Slide 29: Huge US Health Plans - 100M Private Insured Lives
Huge US Health Plans - 100M Private Insured Lives Total Medicare Private Health Plan Enrollment, 1992-2026 (in millions of people) HISTORICAL PROJECTED Medicare Advantage Age 65+ Represents 45% of all 29 30 28 Medicare enrollment in 2022 27 26 25 23 22 21 Commercial – Self-insured 17.6 19 Reseller O
Slide 30: Debut Canadian Public Health Insurer
Debut Canadian Public Health Insurer 522,000 TOTAL POPULATION In 2023, 34% of the population in Newfoundland and Labrador had Diabetes (type 1, type 2 diagnosed and type 2 undiagnosed) and prediabetes combined. Eastern Health is now looking to expand the offering province-wide. 1. “Diabetes in Newfo
Slide 31: Participant Journey
Participant Journey 31
Slide 32: Meet Maria
Meet Maria Age 52 Maria is about to have a Height 5’5” life-changing experience Weight 168 Key Risk Eligibility Blood Pressure HIGH Criteria: Out of range A1C & BMI A1C 6.1% Health Goals: Lose weight - 18 Ib loss BMI 28 Decrease A1C, Cholesterol Increase energy, mood, Readiness CONTEMPLATIVE and sel
Slide 33: Maria's Newtopia Journey
Maria’s Newtopia Journey Watch: Overview Video Invitation to Health Profile v Personality-Matched Inspirator Client Data Sharing & Integrations Welcome Kit Health Goals Achieved Genetic Engagement Engaging Workshops, Community, Gaming & Challenges Personalized Plan Care path referrals & curation New
Slide 34: Maria's Habit Change Team
Maria’s Habit Change Team Humans helping humans. Amplified by technology & data insights. Expert Team Inspirators Care Specialists 34
Slide 35: Technology and Processes Drive Maria's Personalization
Technology and Processes Drive Maria’s Personalization Newtopia 1.0 Platform Know Me Support Me Engage Me Partners • 3PL Personal Profile & Personalized Care 1:1 Coaching • Genetics Scripts, SDoH Journey Experience Labs, Clinics • Data (Connected Devices, iOT)) Biometrics Personality Matched Care Sp
Slide 36: Evolution of Technology & Data Insights for Maria
Evolution of Technology & Data Insights for Maria New Key Features Key Features Hello Maria • Real-time, in-app, live communications • Client specific program onboarding • Proprietary Habit change index (HCI) • Personalized program material • Daily check-in, emotional tracking delivery • Photo and n
Slide 37: Maria's Genetic Engagement
Maria’s Genetic Engagement Body Fat Gene (FTO) How easily do you gain weight? Eating Behavior Gene (DRD2) Do you eat when you’re stressed? Appetite Gene (MC4R) Do you eat until you’re too full? Caffeine Gene (CYP1A2) Caffeine impacts your sleep, stress/anxiety Clock Gene Are you sleeping enough? Exe
Slide 38: Actionable Recommendations for Maria
Actionable Recommendations for Maria NUTRITION ADDRESS THE DELAYED SENSE OF FEELING FULL AND THE EMOTIONAL EATING Higher protein diet: 40% protein 30% carbs • Fill your plate as usual, then put extras away 30% fats immediately • Drink 1-2 glasses of water prior to a meal EXERCISE Work up to • Practi
Slide 39: Maria's Outcomes: 12 months
Age 53 Height 5’5” Maria’s Weight 148 (-12%) Outcomes: Blood Pressure MEDIUM 12 months A1C 5.3% Readiness ACTION PROMIS® WITHIN NORMAL LIMITS Family History HIGH RISK Social Determinants HIGH RISK 39
Slide 40: Who Benefits Most From Maria's Foundational Habit Change
Who Benefits Most From Maria’s Foundational Habit Change 1 Member Engagement 2 Improve Health/Life 3 Decrease Cost of Care/Increase Desired Benefits Utilization Behavior Change Eco System Program Champion Provider Amplification Employers Chronic Diseases Health Plans Primary Care Providers Habit C